Detection of obstructive sleep apnoea by an electronic nose

European Respiratory Journal

Volumn 42, Issue 1, 2013, Pages 145-155

  Greulich, Timm ^a   Hattesohl, Akira ^a   Grabisch, Antje ^a   Koepke, Janine ^a   Schmid, Severin ^a   Noeske, Sarah ^a   Nell, Christoph ^a   Wencker, Marion ^b   Jörres, Rudolf A ^c   Vogelmeier, Claus Franz ^a   Köhler, Ulrich ^a   Koczulla, Andreas Rembert ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ELECTRONIC NOSE; EXPIRED AIR; FEMALE; HUMAN; MALE; PH MEASUREMENT; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; TREATMENT DURATION; UPPER RESPIRATORY TRACT;

ADULT; AGED; AIRWAY REMODELING; CASE-CONTROL STUDIES; DISCRIMINANT ANALYSIS; ELECTRONIC NOSE; EXHALATION; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; POLYSOMNOGRAPHY; QUESTIONNAIRES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; VOLATILE ORGANIC COMPOUNDS;

EID: 84880149430     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00091712     Document Type: Article

References (41)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235. (Pubitemid 23115702)
2. Arzt M, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447-1451. (Pubitemid 43069819)
3. Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003; 41: 1429-1437. (Pubitemid 36543356)
4. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005; 28: 499-521. (Pubitemid 40489844)
5. Bloch KE, Schoch OD, Zhang JN, et al. German version of the Epworth Sleepiness Scale. Respiration 1999; 66: 440-447. (Pubitemid 29431578)
6. Davies RJ, Ali NJ, Stradling JR. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992; 47: 101-105.
7. Williams AJ, Yu G, Santiago S, et al. Screening for sleep apnea using pulse oximetry and a clinical score. Chest 1991; 100: 631-635.
8. Agatsuma T, Fujimoto K, Komatsu Y, et al. A novel device (SD-101) with high accuracy for screening sleep apnoeahypopnoea syndrome. Respirology 2009; 14: 1143-1150.
9. Karunajeewa AS, Abeyratne UR, Hukins C. Multi-feature snore sound analysis in obstructive sleep apnea-hypopnea syndrome. Physiol Meas 2011; 32: 83-97.
10. Corthout J, Van Huffel S, Mendez MO, et al. Automatic screening of obstructive sleep apnea from the ECG based on empirical mode decomposition and wavelet analysis. Conf Proc IEEE Eng Med Biol Soc 2008; 2008: 3608-3611.
11. Carpagnano GE, Spanevello A, Sabato R, et al. Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8. Transl Res 2010; 155: 35-43.
12. Boyd JH, Petrof BJ, Hamid Q, et al. Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170: 541-546. (Pubitemid 39209137)
13. Janciauskiene SM, Bals R, Koczulla R, et al. The discovery of a1-antitrypsin and its role in health and disease. Respir Med 2011; 105: 1129-1139.
14. Sariman N, Levent E, Cubuk R, et al. Bronchial hyperreactivity and airway wall thickening in obstructive sleep apnea patients. Sleep Breath 2011; 15: 341-350.
15. Mattos W, Lim S, Russell R, et al. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 2002; 122: 1543-1552. (Pubitemid 35366062)
16. Moser B, Bodrogi F, Eibl G, et al. Mass spectrometric profile of exhaled breath -field study by PTR-MS. Respir Physiol Neurobiol 2005; 145: 295-300. (Pubitemid 40215660)
17. Thaler ER, Hanson CW. Medical applications of electronic nose technology. Expert RevMed Devices 2005; 2: 559-566. (Pubitemid 41447653)
18. Dragonieri S, Annema JT, Schot R, et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 2009; 64: 166-170.
19. Fens N, Zwinderman AH, van der Schee MP, et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009; 180: 1076-1082.
20. Hattesohl AD, Jorres RA, Dressel H, et al. Discrimination between COPD patients with and without a1-antitrypsin deficiency using an electronic nose. Respirology 2011; 16: 1258-1264.
21. Wilson AD, Baietto M. Advances in electronic-nose technologies developed for biomedical applications. Sensors (Basel) 2011; 11: 1105-1176.
22. Koczulla AR, Noeske S, Herr C, et al. α1-Antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patients. Respir Med 2012; 106: 120-126.
23. Koczulla AR, Noeske S, Herr C, et al. Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers. Respiration 2010; 79: 61-67.
24. Huttmann EM, Greulich T, Hattesohl A, et al. Comparison of two devices and two breathing patterns for exhaled breath condensate sampling. PLoS One 2011; 6: e27467.
25. Altman DG, Bland JM. Diagnostic tests. 1: Sensitivity and specificity. BMJ 1994; 308: 1552.
26. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-35.
27. Lewis NS. Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. Acc Chem Res 2004; 37: 663-672.
28. Shykhon ME, Morgan DW, Dutta R, et al. Clinical evaluation of the electronic nose in the diagnosis of ear, nose and throat infection: a preliminary study. J Laryngol Otol 2004; 118: 706-709. (Pubitemid 39424744)
29. Hockstein NG, Thaler ER, Lin Y, et al. Correlation of pneumonia score with electronic nose signature: A prospective study. Ann Otol Rhinol Laryngol 2005; 114: 504-508. (Pubitemid 40995032)
30. Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005; 171: 1286-1291. (Pubitemid 40740737)
31. Dragonieri S, Schot R, Mertens BJ, et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007; 120: 856-862. (Pubitemid 47542280)
32. Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in patients with preexisting coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 2012; 33: 988-997.
33. Profita M, La Grutta S, Carpagnano E, et al. Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 2006; 118: 1068-1074. (Pubitemid 44679779)
34. Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111: 1665-1672. (Pubitemid 38057748)
35. Koczulla R, Dragonieri S, Schot R, et al. Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients. Respir Res 2009; 10: 78.
36. Carpagnano GE, Kharitonov SA, Resta O, et al. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003; 124: 1386-1392. (Pubitemid 37290049)
37. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009; 33: 1467-1484.
38. Tazaki T, Minoguchi K, Yokoe T, et al. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 170: 1354-1359. (Pubitemid 39657200)
39. Herr C, Beisswenger C, Hess C, et al. Suppression of pulmonary innate host defence in smokers. Thorax 2009; 64: 144-149.
40. Lieberman D, Shleyfer E, Castel H, et al. Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adults. J Clin Microbiol 2006; 44: 525-528. (Pubitemid 43222247)
41. Bossuyt PM, Reitsma JB. The STARD initiative. Lancet 2003; 361: 71.